RYOIX vs. RMQAX
RYOIX (Rydex Biotechnology Fund) and RMQAX (Rydex Monthly Rebalance NASDAQ-100 2x Strategy Fund) are both mutual funds - RYOIX is a Health & Biotech Equities fund managed by Rydex Funds, while RMQAX is a Leveraged Equities fund managed by Rydex Funds. Over the past 10 years, RYOIX returned 9.33%/yr vs 33.71%/yr for RMQAX. Their 0.61 correlation means they have sometimes moved together and sometimes differently. RYOIX charges 1.36%/yr vs 1.32%/yr for RMQAX.
Performance
RYOIX vs. RMQAX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RYOIX achieves a 18.33% return, which is significantly higher than RMQAX's 16.20% return. Over the past 10 years, RYOIX has underperformed RMQAX with an annualized return of 9.33%, while RMQAX has yielded a comparatively higher 33.71% annualized return.
RYOIX
- 1D
- 0.50%
- 1M
- -3.93%
- 6M
- 15.89%
- YTD
- 18.33%
- 1Y
- 50.09%
- 3Y*
- 18.00%
- 5Y*
- 6.19%
- 10Y*
- 9.33%
- ALL TIME*
- 10.91%
RMQAX
- 1D
- 7.48%
- 1M
- -8.91%
- 6M
- 13.97%
- YTD
- 16.20%
- 1Y
- 39.46%
- 3Y*
- 35.28%
- 5Y*
- 17.97%
- 10Y*
- 33.71%
- ALL TIME*
- 31.32%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $0.00 | $0.00 | $0.00 | |
| $0.00 | $0.00 | $0.00 |
RYOIX vs. RMQAX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RYOIX Rydex Biotechnology Fund | 18.33% | 30.62% | -0.95% | 6.06% | -13.04% | 2.05% | 21.94% | 30.69% | -8.94% | 29.68% |
RMQAX Rydex Monthly Rebalance NASDAQ-100 2x Strategy Fund | 16.20% | 33.92% | 44.76% | 115.91% | -59.93% | 56.36% | 101.06% | 80.80% | -7.28% | 69.80% |
Correlation
The correlation between RYOIX and RMQAX is 0.31, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.31 |
Correlation (3Y) Balances recent behavior with more history. | 0.41 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.54 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.60 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2015 | 0.61 |
Over the past year, the correlation between RYOIX and RMQAX has dropped to 0.31 - well below their long-term average of 0.61, suggesting their price drivers have been diverging.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RYOIX vs. RMQAX — Risk / Return Rank
RYOIX
RMQAX
RYOIX vs. RMQAX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Rydex Biotechnology Fund (RYOIX) and Rydex Monthly Rebalance NASDAQ-100 2x Strategy Fund (RMQAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RYOIX | RMQAX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.68 | ||
| Sortino ratioReturn per unit of downside risk | +2.21 | ||
| Omega ratioGain probability vs. loss probability | 1.41 | 1.16 | +0.25 |
| Calmar ratioReturn relative to maximum drawdown | 5.92 | 1.31 | +4.61 |
| Martin ratioReturn relative to average drawdown | 19.14 | 4.05 | +15.09 |
Loading charts...
Drawdowns
RYOIX vs. RMQAX - Drawdown Comparison
The maximum RYOIX drawdown since its inception was -74.43%, which is greater than RMQAX's maximum drawdown of -63.18%. Use the drawdown chart below to compare losses from any high point for RYOIX and RMQAX.
Loading charts...
Drawdown Indicators
| RYOIX | RMQAX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -74.43% | -63.18% | -11.25% |
Max Drawdown (1Y)Largest decline over 1 year | -8.43% | -24.96% | +16.53% |
Max Drawdown (3Y)Largest decline over 3 years | -23.47% | -42.45% | +18.98% |
Max Drawdown (5Y)Largest decline over 5 years | -33.66% | -63.18% | +29.52% |
Max Drawdown (10Y)Largest decline over 10 years | -33.66% | -63.18% | +29.52% |
Current DrawdownCurrent decline from peak | -4.80% | -17.08% | +12.28% |
Average DrawdownAverage peak-to-trough decline | -27.49% | -12.85% | -14.64% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.60% | 8.04% | -5.44% |
Volatility
RYOIX vs. RMQAX - Volatility Comparison
The current volatility for Rydex Biotechnology Fund (RYOIX) is 5.73%, while Rydex Monthly Rebalance NASDAQ-100 2x Strategy Fund (RMQAX) has a volatility of 14.58%. This indicates that RYOIX experiences smaller price fluctuations and is considered to be less risky than RMQAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RYOIX | RMQAX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.73% | 14.58% | -8.85% |
Volatility (6M)Calculated over the trailing 6-month period | 15.28% | 32.55% | -17.27% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.84% | 39.23% | -19.39% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.32% | 47.24% | -25.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.13% | 46.82% | -23.69% |
RYOIX vs. RMQAX - Expense Ratio Comparison
RYOIX has a 1.36% expense ratio, which is higher than RMQAX's 1.32% expense ratio.
Dividends
RYOIX vs. RMQAX - Dividend Comparison
RYOIX's dividend yield for the trailing twelve months is around 10.62%, less than RMQAX's 31.21% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RMQAX Rydex Monthly Rebalance NASDAQ-100 2x Strategy Fund | 31.21% | 36.27% | 26.02% | 3.76% | 0.00% | 2.18% | 5.30% | 0.10% | 0.00% | 0.00% | 0.00% | 0.00% |
RYOIX Rydex Biotechnology Fund | 10.62% | 12.57% | 14.61% | 0.00% | 1.29% | 19.39% | 7.28% | 8.58% | 14.11% | 5.38% | 0.00% | 1.45% |
Frequently Asked Questions
RYOIX and RMQAX have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RMQAX has higher volatility (14.58%) compared to RYOIX (5.73%). In terms of maximum drawdown, RYOIX dropped -74.43% vs RMQAX's -63.18%.
RYOIX currently has the higher Sharpe Ratio (2.52 vs 0.83), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RYOIX and RMQAX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer